Invesco’s Milestone Pharmaceuticals MIST Stock Holding History

Invesco’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$49.2K	Buy	41,356 +19,463	+89%	+$34.1K	﹤0.01%	3695
2025 Q4	$44.2K	Buy	+21,893	New	+$47.2K	﹤0.01%	3718
2020 Q4	–	Sell	-315,404	Closed	-$2.31M	–	3801
2020 Q3	$2.31M	Sell	315,404 -4,973	-2%	-$35.6K	﹤0.01%	2419
2020 Q2	$1.21M	Hold	320,377	–	–	﹤0.01%	2712
2020 Q1	$589K	Sell	320,377 -2,056	-0.6%	-$35.6K	﹤0.01%	2987
2019 Q4	$5.16M	Sell	322,433 -2,567	-0.8%	-$45.4K	﹤0.01%	2145
2019 Q3	$6.06M	Hold	325,000	–	–	﹤0.01%	2022
2019 Q2	$8.82M	Buy	+325,000	New	+$6.7M	﹤0.01%	1829

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Invesco's MIST Position: Q1 2026 in Review

Invesco increased its Milestone Pharmaceuticals (MIST) stake by 89% in Q1 2026, buying an estimated $34.1K and bringing the position to 41,356 shares worth $49.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3695.

Invesco first reported a position in MIST in Q2 2019 and has held it in 8 quarters since. The position peaked at $8.82M in Q2 2019. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

Invesco held 41,356 shares of Milestone Pharmaceuticals worth $49.2K as of Q1 2026.
Invesco bought 19,463 Milestone Pharmaceuticals shares in Q1 2026, an estimated $34.1K.
Milestone Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3695 holding.
Invesco first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 8 quarters since.
Invesco's Milestone Pharmaceuticals position peaked at $8.82M in Q2 2019.
86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.